ShadowBuys
Committee overlap: HELP

Sen. Alan Armstrong sold Abbott Laboratories (ABT)

Sen. Alan Armstrong (R-OK) · $15K–$50K · traded Mar 27, 2026

Why this is a committee overlap

Armstrong is a member of the Senate Committee on Health, Education, Labor, and Pensions, which oversees the Healthcare sector. Abbott Laboratories is classified in the Medical - Devices industry.

An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.

Transaction
Sold (full)
Amount
$15K–$50K
Owner
The member
Traded
Mar 27, 2026
Disclosed
Jul 21, 2026
Days to disclose
116 (after the 45-day deadline)
Asset type
Stock
As filed
Abbott Laboratories Common Stock
Industry
Medical - Devices · Healthcare

Other trades in this filing

All of Armstrong's trades →

Recent Congress trades in ABT

Company context for ABT

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. ABTContract award·USAspending

    ABT: Department of Veterans Affairs contract award

    PH REF LAB INSTRUMENT MAINT

    First observed: Nov 8, 2026, 11:39 AM ESTEvent / period: Sep 9, 2022Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  2. ABTContract award·USAspending

    ABT: Department of Veterans Affairs contract award

    PROPRIETARY LABORATORY INSTRUMENT SUPPORT & MAINTENANCE

    First observed: Nov 8, 2026, 11:39 AM ESTEvent / period: Sep 16, 2022Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  3. ABTContract award·USAspending

    ABT: Department of Veterans Affairs contract award

    APOC ISTAT ANALYZER MAINTENANCE AND REPLACEMENT SERVICE AGREEMENT

    First observed: Nov 8, 2026, 10:57 AM ESTEvent / period: Jan 16, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.